Transcriptional mechanisms of chondrocyte differentiation

Matrix Biology

Volumn 19, Issue 5, 2000, Pages 389-394

  De Crombrugghe, Benoit ^a   Lefebvre, Veronique ^a   Behringer, Richard R ^a   Bi, Weimin ^a   Murakami, Shunichi ^a   Huang, Wendong ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP DEPENDENT PROTEIN KINASE; PROCOLLAGEN; TRANSCRIPTION FACTOR;

CARTILAGE CELL; CELL DIFFERENTIATION; ENHANCER REGION; ENZYME PHOSPHORYLATION; GENE EXPRESSION REGULATION; HUMAN; NONHUMAN; PRIORITY JOURNAL; SHORT SURVEY; TRANSCRIPTION REGULATION;

ANIMALS; CELL DIFFERENTIATION; CHONDROCYTES; GENE EXPRESSION; HIGH MOBILITY GROUP PROTEINS; MODELS, BIOLOGICAL; MUTATION; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC;

EID: 0033813919     PISSN: 0945053X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0945-053X(00)00094-9     Document Type: Short Survey

References (25)

1. Bell, D.M., Leung, K.K.H., Wheatley, S.C. et al., 1997. SOX9 directly regulates the type-II collagen gene. Nat. Genet. 16, 174-178.
2. Bi, W., Deng, J.M., Zhang, Z., Behringer, R.R., de Crombrugghe, B., 1999. Sox9 is required for cartilage formation. Nat. Genet. 22, 85-89.
3. Bridgewater, L.C., Lefebvre, V., de Crombrugghe, B., 1998. Chondrocyte enhancer elements in the Collla2 gene resemble the Col2a1 tissue enhancer. J. Biol. Chem. 273, 14998-15006.
4. Cancedda, R., Descalzi Cancedda, F., Castagnola, P., 1995. Chondrocyte differentiation. Int. Rev. Cytol. 159, 265-358.
5. Cheah, K.S.E., Lau, E.T., Au, P.K.C., Tam, P.P.L., 1991. Expression of the mouse α1(II) collagen gene is not restricted to cartilage during development. Development 111, 945-953.
6. Erlebacher, A., Filvaroff, E.H., Gitelman, S.E., Derynck, R., 1995. Toward a molecular understanding of skeletal development. Cell 80, 271-278.
7. Foster, J.W., Dominguez-Steglich, M.A., Guioli, S. et al., 1994. Campomelic dysplasia and autosomal sex reversal caused by mutations in an SRY-related gene. Nature 372, 525-530.
8. Huang, W., Zhou, X., Lefebvre, V., de Crombrugghe, B., 2000. Phosphorylation of SOX9 by cyclic AMP-dependent protein kinase A enhances SOX9's ability to transactivate a Cola1 chondrocyte-specific enhancer. Mol. Cell Biol. 20, 4149-4158.
9. Karaplis, C.C., Luz, A., Glowacki, J. et al., 1994. Lethal skeletal dysplasia from targeted disruption of the parathyroid hormone-related peptide gene. Genes Dev. 8, 277-289.
10. Lefebvre, V., Huang, W., Harley, V.R., Goodfellow, P.N., de Crombrugghe, B., 1997. SOX9 is a potent activator of the chondrocyte-specific enhancer of the proa1(II) collagen gene. Mol. Cell. Biol. 17, 2336-2346.
11. Lefebvre, V., Li, P., de Crombrugghe, B., 1998. A new long form of Sox5 (L-Sox5), Sox6 and Sox9 are coexpressed in chondrogenesis and cooperatively activate the type II collagen gene. EMBO J. 17, 5718-5733.
12. Lefebvre, V., Zhou, G., Mukhopadhyay, K. et al., 1996. An 18base-pair sequence in the mouse proα1(II) collagen gene is sufficient for cartilage expression and binds nuclear proteins that are selectively expressed in chondrocytes. Mol. Cell. Biol. 16, 4512-4523.
13. Meyer, J., Sudbeck, P., Held, M. et al., 1997. Mutational analysis of the SOX9 gene in campomelic dysplasia and autosomal sex reversal: lack of genotype/phenotype correlations. Hum. Mol. Genet. 6, 91-98.
14. Mukhopadhyay, K., Lefebvre, V., Zhou, G., Garofalo, S., Kimura, J.H., de Crombrugghe, B., 1995. Use of a new rat chondrosarcome cell line to delineate a 119-base pair chondrocyte-specific enhancer element and to define active promoter segments in the mouse pro-α1(II) collagen gene. J. Biol. Chem. 270, 27711-27719.
15. Mundlos, S., Olsen, B.R., 1997a. Heritable diseases of the skeleton. Part I: molecular insights into skeletal development-transcription factors and signaling pathways. FASEB J. 11, 125-132.
16. Mundlos, S., Olsen, B.R., 1997b. Heritable diseases of the skeleton. Part II: molecular insights into skeletal development-matrix components and their homeostasis. FASEB J. 11, 227-233.
17. Murakami, S., Kan, M., McKeehan, W.L., de Crombrugghe, B., 2000. Up-regulation of the chondrogenic Sox9 gene by fibroblast growth factors is mediated by the mitogen-activated protein kinase pathway. Proc. Natl. Acad. Sci. USA 97, 1113-1118.
18. Ng, L.-J., Wheatley, S., Muscat, G.E.O., Conway-Campbell, J. et al., 1997. SOX9 binds DNA, activates transcription, and coexpresses with type II collagen during chondrogenesis in the mouse. Dev. Biol. 183, 108-121.
19. Wagner, T., Wirth, J., Meyer, J., Zabel, B., Held, M., Zimmer, J., Pasantes, J., Bricarelli, F.D., Keutel, J., Hustert, E., Wolf, U., Tommerup, N., Schempp, W., Scherer, G. 1994. Autosomal sex reversal and campomelic dysplasia are caused by mutations in and around the SRY-related gene SOX-9. Cell 79:1111-1120.
20. Wegner, M., 1999. From head to toes: the multiple facets of Sox proteins. Nucleic Acids Res. 27 (6), 1409-1430 (Review).
21. Wright, E., Hargrave, M.R., Christiansen, J. et al., 1995. The Sry-related gene Sox9 is expressed during chondrogenesis in mouse embryos. Nat. Genet. 9, 15-20.
22. Xie, W.F., Zhang, X., Sakano, S., Lefebvre, V., Sandell, L.J., 1999. Trans-activation of the mouse cartilage-derived retinoic acid-sensitive protein gene by Sox9. J. Bone Miner. Res. 14, 757-763.
23. Zhao, Q., Eberspaecher, H., Lefebvre, V., de Crombrugghe, B., 1997. Parallel expression of Sox9 and Col2al in cells undergoing chondrogenesis. Dev. Dynam. 209, 377-386.
24. Zhou, G., Garofalo, S., Mukhopadhyay, K. et al., 1995. A 182 bp fragment of the mouse proal(II) collagen gene is sufficient to direct chondrocyte expression in transgenic mice. J. Cell Sci. 108, 3677-3684.
25. Zhou, G., Lefebvre, V., Zhang, Z., Eberspeacher, H., de Crombrugghe, B., 1998. Three high mobility group-like sequences within a 48-base pair enhancer of the Col2al gene are required for cartilage-specific expression in vivo. J. Biol. Chem. 273, 14989-14997.